跳至主要内容
临床试验/ITMCTR1900002782
ITMCTR1900002782尚未招募未知

Study for the regulation mechanism of body immune function by meditation

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
20 至 60(—)
性别
All

入选标准

  • (1) healthy physical examination (routine hematuria and stool, liver and kidney function + blood lipid), and did not complain of obvious discomfort;
  • (2) Aged 20 to 60 years old;
  • (3) BMI 18.5 to 23.9;
  • (4) nearly 3 months did not use antibiotics;
  • (5) have not used gastrointestinal motility drugs, acid-suppressants, microecological preparations or immunosuppressants in the past 3 weeks;
  • (6) subjects in the meditation group received meditation training for more than 3 years;
  • (7) the subjects in the control group have never received any form of meditation training (such as qigong, yoga, taijiquan, baduanjin, etc.);
  • (8) agree to participate in the study and sign informed consent.

排除标准

  • (1) with serious mental and psychological diseases and major chronic diseases;
  • (2) pregnancy or lactation period;
  • (3) a history of alcohol or drug abuse;
  • (4) is participating in other clinical researchers.

研究者

发起方
Beijing University of Chinese Medicine

相似试验

已完成
不适用
Pilotstudy about the role of regulatory immune cells in autoimmunity, cancer and organ rejection after kidney transplantatioSystemic sclerosisE10M06M32M34C18Z94.0Other rheumatoid arthritisMalignant neoplasm of colonKidney transplant statusType 1 diabetes mellitusSystemic lupus erythematosus
DRKS00026238Medizinische Universität Graz, Department für Innere Medizin, Abteilung für Endokrinologie und Diabetologie485
进行中(未招募)
1 期
Mechanistic study assessing the immunological response of subjects after treatment with different formulations of sublingual immunotherapy. - Assessing the immunological response after sublingual immunotherapy
EUCTR2006-002123-17-GBImperial College London30
已完成
不适用
Exploratory study on mechanism of action and immune-related biomarkers in patients with salivary gland cancer who received trastuzumab delxtecasalivary gland carcinoma
JPRN-UMIN000044278Hokkaido University Hospital Medical oncology52
尚未招募
1 期
Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic Perfusio
ITMCTR2000002965Xianyang Central Hospital
进行中(未招募)
1 期
Immunomonitoring anti-PD1 dans le mélanome métastatiqueAdvanced metastatic melanoma in adultsMedDRA version: 18.0Level: PTClassification code 10027480Term: Metastatic malignant melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2014-003120-48-FRHospices Civils de Lyon40